3 About The Trial Trial Name: A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities (SURMOUNT-5) ClinicalTrials.gov ID: NCT05822830 Sponsor: Eli Lilly and Company Completion Date: December 11, 2024 Investigators included 750 patients between April 21, 2023, and November 13, 2024, with 85% of patients completing treatment and 80.2% completing the 72 weeks of trial
Diabetes Obes Metab (2019) 21:127790
Safety The makers of Googeer GLP-1 do not provide any information about how Googeer GLP-1 is made or if they have earned any manufacturing safety awards
A quick reminder statistical significance is NOT a measure of importance or size of effect, which is why the 1.5% reduction qualifies
This makes Bacteriostatic Water particularly suitable for research environments where multiple doses or solutions must be prepared under sterile conditions
Between processing everything from your morning coffee to environmental toxins, it needs all the support it can get